Latest News
Neurocrine agrees acquisition of Soleno Therapeutics
7 April 2026 - US biopharmaceutical companies Neurocrine Biosciences Inc (Nasdaq:NBIX) and Soleno Therapeutics Inc (Nasdaq:SLNO) announced on Monday that Neurocrine has entered into a definitive agreement to acquire Soleno for USD53.00 per share in c...
NeuroSense's PrimeC composition receives Brazilian patent
7 April 2026 - NeuroSense Therapeutics Ltd (NASDAQ:NRSN), a late-clinical stage biotechnology company developing treatments for severe neurodegenerative diseases, announced on Monday that the Brazilian Patent and Trademark Office (INPI) has granted B...
Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data
7 April 2026 - Chinese biopharmaceutical company Akeso Inc (HK:9926) said on Monday that, at the 2026 European Lung Cancer Congress (ELCC 2026), it reported updated results with a median follow-up of 21.45 months from a prospective, open-label, singl...
Upsher-Smith launches generic version of Ciprodex ear drop suspension
7 April 2026 - US pharmaceutical company Upsher-Smith Laboratories LLC, a subsidiary of Taiwan-based Bora Pharmaceuticals Co Ltd (TW:6472) (OTCQX:BORAY) announced on Monday the launch of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP....
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
...